Glycopyrrolate Injection
Product Images NDC 55154-7475

2 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 55154-7475). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Glycopyrrolate Injection 1)

Chemical Structure (Glycopyrrolate Injection 1)
Chemical structure of Glycopyrrolate showing its molecular composition with carbon, hydrogen, oxygen, nitrogen atoms, and bromide ion. The molecular formula (C19H28BrNO3) and molecular weight (398.33) are also displayed.*
FDA Label Image

0.2mg/ml Bag Label (8ed339c6 D65f 4b1c 8e23 301f75258c2e 00)

0.2mg/ml Bag Label (8ed339c6 D65f 4b1c 8e23 301f75258c2e 00)
Drug facts label for Glycopyrrolate Injection, USP 0.2 mg/mL in 5 single dose 1 mL vials. Instructions specify use for intramuscular or intravenous administration, storage conditions, and warnings including the presence of benzyl alcohol and non-use in newborns. The label states it is RX only, intended for institutional use, and lists manufacturers and distributors including Hikma Farmaceutica and Cardinal Health.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.